BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2633699)

  • 1. [Immunostimulating properties of synthetic derivatives of muramyl dipeptide and glucosaminyl muramyl dipeptide in vitro].
    Rakhmilevich AL; Migdal TL; Rakhimova MS; Shneĭderova MA; Chirva VIa; Zemliakov AE
    Antibiot Khimioter; 1989 Nov; 34(11):836-9. PubMed ID: 2633699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunostimulating effects of muramyl dipeptide, glucosaminyl muramyl dipeptide and their synthetic derivatives in vitro].
    Rakhmilevich AL; Rakhimova MS; Andronova TM; Bovin NV
    Antibiot Khimioter; 1989 Aug; 34(8):586-9. PubMed ID: 2589897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
    Medvedev AE; Fuks BB; Bovin NV; Zemliakov AE
    Biull Eksp Biol Med; 1992 Dec; 114(12):626-8. PubMed ID: 1292694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activation of cellular immunity in mice under normal conditions and in tumor growth during treatment with glucosaminyl muramyl dipeptide].
    Pimenov AA; Rakhmilevich AL; Deev VV; Kirillova IV; Migdal TL; Andronova TM; Fuks BB
    Vopr Med Khim; 1990; 36(1):58-60. PubMed ID: 2343578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive immunomodulating properties and interactivity with model membranes and cells of two homologous muramyl dipeptide derivatives differing by their lipophilicity.
    Kalyuzhin OV; Zemlyakov AE; Fuchs BB
    Int J Immunopharmacol; 1996 Nov; 18(11):651-9. PubMed ID: 9089008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
    Le Contel C; Temime N; Charron DJ; Parant MA
    J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of colony-stimulating factor from macrophages by muroctasin.
    Yamaguchi F; Akahane K; Takashi T; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of configuration of muramyl dipeptide glycoside bond and structure of glycoside aglycon on their capacity to stimulate production of interleukin-1 and tumor necrosis factor by macrophages.
    Kalyuzhin OV; Nelyubov MV; Kalyuzhina EV; Kuzovlev FN; Shkalev MV
    Bull Exp Biol Med; 2002 Sep; 134(3):281-3. PubMed ID: 12512003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
    Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
    Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of immunomodulatory properties of muramyl peptides on immune system cells of young and old mice.
    Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):149-63. PubMed ID: 8077604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues.
    Saiki I; Saito S; Fujita C; Ishida H; Iida J; Murata J; Hasegawa A; Azuma I
    Vaccine; 1988 Jun; 6(3):238-44. PubMed ID: 2844032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The schistosomulicidal activity and the production of IL-1 and TNF-alpha by peritoneal macrophages from infected mice and their potentiation by muramyl tripeptide-phosphatidyl ethanolamine (MTP-PE) treatment.
    Seger M; Gold D; Lengy J; Pauli H; Keisari Y
    Parasite Immunol; 1993 Jun; 15(6):339-47. PubMed ID: 8361776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of liposomal glucosaminyl-muramyl dipeptide on superoxide and nitric oxide production by murine macrophages].
    Parshykov OV; Stefanov OV
    Ukr Biokhim Zh (1999); 2009; 81(5):74-82. PubMed ID: 20387650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in interleukin 1 (IL-1), IL-6, tumor necrosis factor and IL-1 receptor antagonist production by human monocytes stimulated with muramyl dipeptide (MDP) and its stearoyl derivative, romurtide.
    Suzuki K; Torii K; Hida S; Hayashi H; Hiyama Y; Oomoto Y; Takii T; Chiba T; Onozaki K
    Immunopharmacology; 1994; 28(1):31-8. PubMed ID: 7928300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modulation of tumour necrosis factor-alpha, interleukin-1 alpha and glucose levels with GMDP and other analogues of muramyl dipeptide.
    Adeleye TA; Moreno C; Ivanyi J; Aston R
    APMIS; 1994 Feb; 102(2):145-52. PubMed ID: 8167010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent.
    Nagao S; Akagawa KS; Yamada K; Yagawa K; Tokunaga T; Kotani S
    Microbiol Immunol; 1990; 34(3):323-35. PubMed ID: 2352499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activation of the production of the tumor-necrosis factor by the combined action of lipopolysaccharide and muramyl dipeptide in vitro and in vivo].
    Fuks BB; Rakhmilevich AL; Pimenov AA; Dubrovskaia AG
    Biull Eksp Biol Med; 1987 Oct; 104(10):497-9. PubMed ID: 3315036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming effect of muramyl peptides for induction by lipopolysaccharide of tumor necrosis factor production in mice.
    Parant M; Parant F; Vinit MA; Jupin C; Noso Y; Chedid L
    J Leukoc Biol; 1990 Feb; 47(2):164-9. PubMed ID: 2303750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muramylpeptides augment expression of Ia-antigens on mouse macrophages.
    Nesmeyanov VA; Khaidukov SV; Komaleva RL; Andronova TM; Ivanov VT
    Biomed Sci; 1990 Feb; 1(2):151-4. PubMed ID: 2102779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muramyl dipeptide induces production of hemopoietic growth factors in vivo by a mechanism independent of tumor necrosis factor.
    Broudy VC; Kaushansky K; Shoemaker SG; Aggarwal BB; Adamson JW
    J Immunol; 1990 May; 144(10):3789-94. PubMed ID: 1692060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.